A French biotech had developed a live biotherapeutic product to target obesity and metabolic disease but were hindered by blocking points in the product development process. We worked alongside the Client to identify the specific regulatory and scientific gaps in their plan. This critical information helped to form the solid foundation of their regulatory strategy and nonclinical development plan.
Download the full Case study now
Thank you !
Your file is ready to download.
You will receive by email a download link in a few minutes.